KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd’s (MGRC) net profit surged almost 10-fold to RM1.96mil in the third quarter ended March 31 from RM200,000 a year earlier.
The higher profit was led by a higher margin generated by the distribution of immunotherapy and cell therapies.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!